Clinical Trial Update: A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating the immunogenicity and safety of Minhai's PCV13-DT/TT vaccine versus Pfizer's PCV13 vaccine, and the trial is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Minhai PCV13-DT/TT vaccine (PCV13-DT/TT conjugate vaccine)
• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Beijing Minhai Biotechnology Co., Ltd | Conditions: Pneumococcal Vaccines, Pneumococcal Infections | Phase 3 | Status: RECRUITING